0001104659-20-104488.txt : 20200911
0001104659-20-104488.hdr.sgml : 20200911
20200911171949
ACCESSION NUMBER: 0001104659-20-104488
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200909
FILED AS OF DATE: 20200911
DATE AS OF CHANGE: 20200911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: PRENDERGAST FRANKLYN G
CENTRAL INDEX KEY: 0001233256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35963
FILM NUMBER: 201171767
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuBase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001173281
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465622433
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
BUSINESS PHONE: 6464501790
MAIL ADDRESS:
STREET 1: 700 TECHNOLOGY DRIVE
CITY: PITTSBURGH
STATE: PA
ZIP: 15219
FORMER COMPANY:
FORMER CONFORMED NAME: Ohr Pharmaceutical Inc
DATE OF NAME CHANGE: 20090819
FORMER COMPANY:
FORMER CONFORMED NAME: BBM HOLDINGS, INC.
DATE OF NAME CHANGE: 20070402
FORMER COMPANY:
FORMER CONFORMED NAME: PRIME RESOURCE INC
DATE OF NAME CHANGE: 20020513
4
1
tm2030658d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-09-09
0
0001173281
NeuBase Therapeutics, Inc.
NBSE
0001233256
PRENDERGAST FRANKLYN G
C/O 700 TECHNOLOGY DRIVE, THIRD FLOOR
PITTSBURGH
PA
15219
1
0
0
0
Stock option (right to buy)
8.80
2020-09-09
4
A
0
14634
0
A
2030-09-09
Common Stock
14634
14634
D
25% of the total shares shall vest on the first anniversary of September 9, 2020, and the remaining shares shall vest on an equal monthly basis over the following 36 months.
The power of attorney under which this form was signed is on file with the Commission.
/s/ Sam Backenroth, as attorney-in-fact for Franklyn G. Prendergast
2020-09-11